We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Preventing Sexual Violence in Conflict Initiative (PSVI) aims to raise awareness of the extent of sexual violence against women, men, girls and boys in situations of armed conflict and rally global action to end it. PSVI is part of...
Study on fires involving solar photovoltaic (PV) systems.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
The Preventing Sexual Violence in Conflict Initiative (PSVI) aims to raise awareness of the extent of sexual violence against women, men, girls and boys in situations of armed conflict and rally global action to end it.
The CSSF is a unique cross-government fund that tackles conflict, stability and security challenges overseas which threaten UK national security.
PHE analysis suggests the UK COVID-19 vaccination programme has so far prevented thousands of deaths in those aged 60 and above.
What road hauliers must do when travelling to the UK, to prevent people using their vehicles to enter the UK illegally.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.